Literature DB >> 5435488

Nuclear-magnetic-resonance and mass-spectral examination of the principal bile alcohol from Catostomus commersoni and its anhydro derivative.

L Tökés.   

Abstract

On the basis of i.r. and chromatographic evidence 5alpha-cholestane-3alpha,7alpha,12alpha,24xi,26-pentol(I) and 24xi,26-oxido-5alpha-cholestane-3alpha,7alpha,12alpha-triol (IV) structures have been proposed for the principal cleavage and alkaline-hydrolysis products of the bile salts from Catostomus commersoni (Anderson & Haslewood, 1969). N.m.r.- and mass-spectral analyses of these substances and the tetra- (II) and penta-acetate (III) derivatives of (I) provided supporting evidence for the structural assignments.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5435488      PMCID: PMC1185403          DOI: 10.1042/bj1160585

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  A nuclear magnetic resonance spectral study of cyprinol.

Authors:  A D Cross
Journal:  Biochem J       Date:  1964-02       Impact factor: 3.857

2.  Nuclear-magnetic-resonance and mass-spectral analysis of ranol tetra-acetate.

Authors:  A D Cross
Journal:  Biochem J       Date:  1964-02       Impact factor: 3.857

3.  Comparative studies of 'bile salts'. 18. The chemistry of cyprinol.

Authors:  I G Anderson; T Briggs; G A Haslewood
Journal:  Biochem J       Date:  1964-02       Impact factor: 3.857

4.  Comparative studies of bile salts. Bile salts of the lamprey Petromyzon marinus L.

Authors:  G A Haslewood; L Tökés
Journal:  Biochem J       Date:  1969-09       Impact factor: 3.857

5.  Comparative studies of bile salts. 5 alpha-Chimaerol, a new bile alcohol from the white sucker Catostomus commersoni Lacépède.

Authors:  I G Anderson; G A Haslewood
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

  5 in total
  1 in total

Review 1.  The allure of mass spectrometry: From an earlyday chemist's perspective.

Authors:  László Tőkés
Journal:  Mass Spectrom Rev       Date:  2016-03-21       Impact factor: 10.946

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.